Does Mounjaro (tirzepatide) cause gout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Mounjaro (Tirzepatide) Cause Gout?

No, Mounjaro (tirzepatide) does not cause gout based on available evidence. There is no documented association between tirzepatide and gout development or hyperuricemia in the medical literature.

Understanding the Evidence Gap

The provided evidence extensively discusses medications that do cause gout—specifically diuretics, pyrazinamide, and other agents that interfere with renal uric acid excretion 1, 2. However, tirzepatide is notably absent from any discussion of gout-inducing medications.

  • The clinical trial comparing tirzepatide to semaglutide in 1,879 patients over 40 weeks reported gastrointestinal side effects (nausea, diarrhea, vomiting) and hypoglycemia as the primary adverse events, with no mention of gout or hyperuricemia 3
  • Known drug-induced gout typically results from medications that interfere with renal tubular urate excretion (diuretics, pyrazinamide, ethambutol, cyclosporin) or increase uric acid formation (cytotoxic agents, fructose) 2
  • Tirzepatide's mechanism as a dual GIP/GLP-1 receptor agonist does not involve pathways that would affect uric acid metabolism 3

Actual Risk Factors for Gout to Consider

When evaluating gout risk in patients on tirzepatide, focus on these established factors 4:

  • Diuretic use (odds ratio 1.72) - the most common medication-related cause 1, 5
  • Obesity - which tirzepatide actually helps reduce 3
  • Diet rich in meat, seafood, and fructose-containing beverages 1, 4
  • Alcohol consumption, particularly beer and spirits 1
  • Chronic kidney disease 4

Clinical Implications

If a patient on tirzepatide develops gout, investigate other causes rather than attributing it to the medication. The substantial weight loss achieved with tirzepatide (1.9-5.5 kg greater than semaglutide) 3 may actually reduce gout risk long-term, as weight loss is recommended for gout management 1.

Common Pitfall to Avoid

Do not confuse tirzepatide with medications that genuinely cause hyperuricemia. The rare case report of euglycemic ketoacidosis with tirzepatide 6 represents a different metabolic complication entirely unrelated to uric acid metabolism or gout.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced gout.

Bailliere's clinical rheumatology, 1991

Research

Gout: Rapid Evidence Review.

American family physician, 2020

Guideline

Diuretics and Gout: Alternatives to Reduce Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.